Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma [0.03%]
肺腺癌病理T1分期与影响预后因素的关系分析
Hironori Ninomiya,Kentaro Inamura,Mingyon Mun et al.
Hironori Ninomiya et al.
Introduction: The eight TNM classification of lung tumors provides a more precise prediction of prognosis than previous classification systems, especially in T1 tumors, the invasion size of which are less than or equal to...
Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States [0.03%]
美国肺癌晚期患者可能由于污名化导致治疗率偏低且与指南不符
Terrance Peng,Heidi A Hamann,Elizabeth A David
Terrance Peng
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study [0.03%]
非小细胞肺癌症状评估问卷（NSCLC-SAQ）：来自III期研究的测量属性和临床意义阈值估算
Paul Williams,Thomas Burke,Josephine M Norquist et al.
Paul Williams et al.
Introduction: The NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to assess NSCLC symptom severity in accordance with Food and Drug Administration evidentiary expectations leading to Food and Drug Adminis...
Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice [0.03%]
大型学术社区实践中的肺癌治疗和结果的性别差异
Nickolas Stabellini,Debora S Bruno,Mantas Dmukauskas et al.
Nickolas Stabellini et al.
Introduction: Lung cancer is the leading cause of cancer-related death and the second most often diagnosed malignancy worldwide. Males have higher incidence of lung cancer and higher mortality. It is hypothesized that the...
Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules [0.03%]
基于临床逻辑和机器学习的肺结节评估模型的全面分析
Kai Zhang,Zihan Wei,Yuntao Nie et al.
Kai Zhang et al.
Introduction: Over the years, multiple models have been developed for the evaluation of pulmonary nodules (PNs). This study aimed to comprehensively investigate clinical models for estimating the malignancy probability in...
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study [0.03%]
一项前瞻性试点研究的结果：在诊断组织活检时进行血浆基因分型可缩短晚期NSCLC患者的治疗时间
Jeffrey C Thompson,Charu Aggarwal,Janeline Wong et al.
Jeffrey C Thompson et al.
Introduction: The availability of targeted therapies has transformed the management of advanced NSCLC; however, most patients do not undergo guideline-recommended tumor genotyping. The impact of plasma-based next-generati...
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC [0.03%]
RELAY+： ramucirumab联合吉非替尼治疗EGFR突变的晚期NSCLC患者的探索性研究
Makoto Nishio,Kazuto Nishio,Martin Reck et al.
Makoto Nishio et al.
Introduction: Ramucirumab (RAM) plus erlotinib was found to have superior progression-free survival (PFS) versus placebo plus erlotinib in untreated EGFR-mutated metastatic NSCLC in the global phase 3 RELAY study. RELAY+ ...
Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications [0.03%]
卢旺达国王费萨尔医院肺癌分子检测趋势及治疗和生存影响
Achille Van Christ Manirakiza,Fidel Rubagumya,Eulade Rugengamanzi et al.
Achille Van Christ Manirakiza et al.
Introduction: Lung cancer is the leading cause of cancer mortality worldwide, both in high and low resource settings. Knowledge has been generated elsewhere regarding molecular subtyping and subsequent targeted therapy de...
Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry [0.03%]
基于患者跟踪系统和计算机注册的肺结节偶然发现改进肺癌诊断阶段
Laurie L Carr,Debra S Dyer,Pearlanne T Zelarney et al.
Laurie L Carr et al.
Introduction: Given that an incidental pulmonary nodule (IPN) on chest computed tomography (CT) may represent nascent lung cancer, timely follow-up imaging is critical to assess nodule growth and the need for tissue sampl...
Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia [0.03%]
一线使用下一代测序进行晚期非小细胞肺癌检测在东亚的临床和经济影响分析
Herbert H Loong,Carlos K H Wong,Catherine P K Chan et al.
Herbert H Loong et al.
Introduction: Upfront next-generation sequencing (NGS) in patients with metastatic NSCLC has been associated with cost savings and shorter time-to-test results in the United States. Nevertheless, this may not apply in jur...